Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
- Hormonothérapie
- Immunothérapie - Vaccinothérapie
Extract
A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (KEYNOTE-756)